Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Bertrand Audoin | No disclosure on file |
| Jean Pelletier, MD, PhD (Dpt of Neurology, CHU Timone) | Dr. Pelletier has nothing to disclose. |
| Jean C. Ouallet (Dept of Neurology S258) | Jean C. Ouallet has nothing to disclose. |
| Patrice Desbordes | No disclosure on file |
| David Brassat, MD, PhD (Roche) | No disclosure on file |
| Giovanni Castelnovo | No disclosure on file |
| Eric Thouvenot, MD, PhD (CHU De Nimes - Hopital Caremeau) | Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche. |
| No disclosure on file | |
| Caroline Arquizan | No disclosure on file |
| Xavier Ayrignac | Xavier Ayrignac has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Laurent Magy, MD (Chru Dupeytren, Neurology Dept) | No disclosure on file |
| No disclosure on file | |
| Romain Lefaucheur (Hopital Charles Nicolle) | No disclosure on file |
| Jerome De Seze | Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. |
| Christine Tranchant, MD (Hopital Civil) | No disclosure on file |
| Anne Chiaramello, PhD (George Washington University School of Medicine and Health Sciences) | Dr. Chiaramello has nothing to disclose. |
| Yannick Bejot | No disclosure on file |
| No disclosure on file | |
| Jean-Phillippe Camdessanche | Jean-Phillippe Camdessanche has nothing to disclose. |
| Fernando Pico, MD (Centre Hospitalier De Versailles) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Patricia Mulero | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Dimitri Psimaras, MD (Hopital Salpetrière ; Service) | No disclosure on file |
| Khe Hoang-Xuan, MD | No disclosure on file |
| Pierre Labauge, MD | Dr. Labauge has nothing to disclose. |